TY - JOUR
T1 - Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway
AU - Vanyai, Hannah K.
AU - Prin, Fabrice
AU - Guillermin, Oriane
AU - Marzook, Bishara
AU - Boeing, Stefan
AU - Howson, Alexander
AU - Saunders, Rebecca E.
AU - Snoeks, Thomas
AU - Howell, Michael
AU - Mohun, Timothy J.
AU - Thompson, Barry
N1 - Publisher Copyright:
© 2020. Published by The Company of Biologists Ltd
PY - 2020/11
Y1 - 2020/11
N2 - The Hippo-YAP/TAZ pathway is an important regulator of tissue growth, but can also control cell fate or tissue morphogenesis. Here, we investigate the function of the Hippo pathway during the development of cartilage, which forms the majority of the skeleton. Previously, YAP was proposed to inhibit skeletal size by repressing chondrocyte proliferation and differentiation. We find that, in vitro, Yap/Taz double knockout impairs murine chondrocyte proliferation, whereas constitutively nuclear nls-YAP5SA accelerates proliferation, in line with the canonical role of this pathway in most tissues. However, in vivo, cartilage-specific knockout of Yap/Taz does not prevent chondrocyte proliferation, differentiation or skeletal growth, but rather results in various skeletal deformities including cleft palate. Cartilage-specific expression of nls-YAP5SA or knockout of Lats1/2 do not increase cartilage growth, but instead lead to catastrophic malformations resembling chondrodysplasia or achondrogenesis. Physiological YAP target genes in cartilage include Ctgf, Cyr61 and several matrix remodelling enzymes. Thus, YAP/TAZ activity controls chondrocyte proliferation in vitro, possibly reflecting a regenerative response, but is dispensable for chondrocyte proliferation in vivo, and instead functions to control cartilage morphogenesis via regulation of the extracellular matrix.
AB - The Hippo-YAP/TAZ pathway is an important regulator of tissue growth, but can also control cell fate or tissue morphogenesis. Here, we investigate the function of the Hippo pathway during the development of cartilage, which forms the majority of the skeleton. Previously, YAP was proposed to inhibit skeletal size by repressing chondrocyte proliferation and differentiation. We find that, in vitro, Yap/Taz double knockout impairs murine chondrocyte proliferation, whereas constitutively nuclear nls-YAP5SA accelerates proliferation, in line with the canonical role of this pathway in most tissues. However, in vivo, cartilage-specific knockout of Yap/Taz does not prevent chondrocyte proliferation, differentiation or skeletal growth, but rather results in various skeletal deformities including cleft palate. Cartilage-specific expression of nls-YAP5SA or knockout of Lats1/2 do not increase cartilage growth, but instead lead to catastrophic malformations resembling chondrodysplasia or achondrogenesis. Physiological YAP target genes in cartilage include Ctgf, Cyr61 and several matrix remodelling enzymes. Thus, YAP/TAZ activity controls chondrocyte proliferation in vitro, possibly reflecting a regenerative response, but is dispensable for chondrocyte proliferation in vivo, and instead functions to control cartilage morphogenesis via regulation of the extracellular matrix.
KW - Cartilage
KW - Hippo pathway
KW - Mouse embryo
KW - TAZ
KW - YAP
UR - http://www.scopus.com/inward/record.url?scp=85096152644&partnerID=8YFLogxK
U2 - 10.1242/dev.187187
DO - 10.1242/dev.187187
M3 - Article
SN - 0950-1991
VL - 147
JO - Development (Cambridge)
JF - Development (Cambridge)
IS - 21
M1 - dev187187
ER -